Roiled by C-suite turmoil and a CRL, Immunomedics salutes CMO Rob Iannone as he makes a quick exit
Just days after celebrating his first anniversary as chief medical officer at Immunomedics $IMMU, I/O vet Rob Iannone is hitting the exit door.
In a statement out this morning, Iannone said he was making another career leap to Pennsylvania, going where he could be close to his family “after many years of having worked far away from home.” The cancer R&D vet, who jumped to Immunomedics after a stint at AstraZeneca, didn’t mention exactly where he’s headed.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.